Passage Bio (PASG) News Today $0.33 +0.03 (+8.97%) As of 02:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PASG Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Wedbush Issues Pessimistic Estimate for Passage Bio EarningsMay 18, 2025 | americanbankingnews.comPassage Bio Reports Q1 2025 Financial Results and Highlights Progress in Gene Therapy DevelopmentMay 17, 2025 | msn.comPassage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business HighlightsMay 13, 2025 | globenewswire.comPassage Bio (PASG) Expected to Announce Earnings on TuesdayMay 12, 2025 | americanbankingnews.comInsider Selling: Passage Bio, Inc. (NASDAQ:PASG) Major Shareholder Sells 68,195 Shares of StockApril 25, 2025 | insidertrades.comPassage Bio, Inc. (NASDAQ:PASG) Major Shareholder Orbimed Advisors Llc Sells 77,090 SharesApril 18, 2025 | insidertrades.comOrbiMed Advisors vend des actions de Passage Bio pour 49.704$April 18, 2025 | fr.investing.comL’action PASG atteint son plus bas niveau sur 52 semaines à 0,3$ face aux défis du marchéApril 8, 2025 | fr.investing.comL’action de Passage Bio chute à un plus bas de 52 semaines à 0,35$March 31, 2025 | fr.investing.comL'action Passage Bio chute à son plus bas niveau sur 52 semaines à 0,38$March 14, 2025 | fr.investing.comL’action Passage Bio chute à son plus bas niveau sur 52 semaines à 0,45$March 5, 2025 | fr.investing.comPassage Bio price target lowered to $6 from $7 at ChardanMarch 5, 2025 | markets.businessinsider.comPassage Bio reports FY24 EPS ($1.07) vs ($1.86) last yearMarch 4, 2025 | markets.businessinsider.comPassage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business HighlightsMarch 4, 2025 | globenewswire.comPassage Bio to Participate in Upcoming Investor ConferencesFebruary 26, 2025 | globenewswire.comPassage Bio will again trim workforce in latest cost-cutting moveFebruary 16, 2025 | bizjournals.comLa directrice financière de Passage Bio cède des actions pour 1.685$February 12, 2025 | fr.investing.comPassage Bio CFO sells shares worth $1,685February 12, 2025 | msn.comLes actions de Passage Bio passent au Nasdaq Capital MarketFebruary 1, 2025 | fr.investing.comPassage Bio shares transition to Nasdaq Capital MarketFebruary 1, 2025 | msn.comInsider Selling: Passage Bio, Inc. (NASDAQ:PASG) Major Shareholder Sells 17,986 Shares of StockJanuary 15, 2025 | insidertrades.comOrbimed advisors réduit sa participation dans Passage Bio pour 142.223$January 14, 2025 | fr.investing.comPassage Bio Reports Promising Data in Trial for Frontotemporal Dementia TreatmentJanuary 11, 2025 | msn.comPassage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business UpdatesJanuary 10, 2025 | globenewswire.comInsider Selling: Passage Bio, Inc. (NASDAQ:PASG) Major Shareholder Sells 19,481 Shares of StockJanuary 9, 2025 | insidertrades.comOrbiMed Advisors vend des actions de Passage Bio pour 103.305$January 8, 2025 | fr.investing.comLynx1 Capital Management Lp Purchases 373,645 Shares of Passage Bio, Inc. (NASDAQ:PASG) StockJanuary 1, 2025 | insidertrades.comWill Passage Bio (NASDAQ:PASG) Spend Its Cash Wisely?December 29, 2024 | finance.yahoo.comOrbimed Advisors vend pour 138.192$ d'actions de Passage BioDecember 27, 2024 | fr.investing.comOrbimed Advisors Llc Sells 230,321 Shares of Passage Bio, Inc. (NASDAQ:PASG) StockDecember 27, 2024 | insidertrades.comPassage Bio, Inc. (NASDAQ:PASG) Major Shareholder Orbimed Advisors Llc Sells 54,181 SharesDecember 12, 2024 | insidertrades.comOrbimed Advisors vend pour 51.988$ d'actions de Passage BioDecember 12, 2024 | fr.investing.comInsider Selling: Passage Bio, Inc. (NASDAQ:PASG) Major Shareholder Sells 20,903 Shares of StockDecember 7, 2024 | insidertrades.comOrbiMed Advisors vend des actions de Passage Bio pour une valeur de 77.338€December 6, 2024 | fr.investing.com2,455,800 Shares in Passage Bio, Inc. (NASDAQ:PASG) Purchased by Erste Asset Management GmbHErste Asset Management GmbH bought a new stake in Passage Bio, Inc. (NASDAQ:PASG - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,455,800 shares of the company's stock, valued at approximately $1,718,000. EDecember 4, 2024 | marketbeat.comOptimistic Buy Rating for Passage Bio Driven by Promising PBFT02 Therapy Potential and Accelerated Approval PathwayDecember 3, 2024 | markets.businessinsider.comPassage Bio (NASDAQ:PASG) Stock, Option ChainNovember 30, 2024 | benzinga.comPassage Bio assumed with an Outperform at WedbushNovember 30, 2024 | finance.yahoo.comPassage Bio, Inc. (NASDAQ:PASG) Major Shareholder Lynx1 Capital Management Lp Acquires 29,300 SharesNovember 28, 2024 | insidertrades.comPassage Bio enregistre 284.519 dollars d'achats d'actions par Lynx1 CapitalNovember 28, 2024 | fr.investing.comLe titre de Passage Bio atteint un plus bas de 52 semaines à 0,54 $ face aux défis du marchéNovember 16, 2024 | fr.investing.comTD Cowen Keeps Their Buy Rating on Passage Bio (PASG)November 15, 2024 | markets.businessinsider.comPassage Bio CEO Will Chou to Share Insights at Guggenheim Healthcare Innovation Conference!November 8, 2024 | msn.comPassage Bio to Present at Guggenheim Securities Healthcare Innovation ConferenceNovember 6, 2024 | globenewswire.comPassage Bio présente des avancées dans la thérapie génique pour la démenceOctober 25, 2024 | fr.investing.comPassage Bio delivered preclinical, interim data at ESGCTOctober 25, 2024 | markets.businessinsider.comPassage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual ConferenceOctober 24, 2024 | globenewswire.comLe titre de Passage Bio atteint un plus bas de 52 semaines à 0,55$ face aux défis du marchéOctober 17, 2024 | fr.investing.comLe cours de l'action Passage Bio atteint un plus bas de 52 semaines à 0,57 $ face aux défis du marchéOctober 7, 2024 | fr.investing.comPassage Bio (NASDAQ:PASG) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.com Get Passage Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PASG and its competitors with MarketBeat's FREE daily newsletter. Email Address PASG Media Mentions By Week PASG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PASG News Sentiment▼-0.590.65▲Average Medical News Sentiment PASG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PASG Articles This Week▼51▲PASG Articles Average Week Get Passage Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PASG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ZURA News ELUT News VTGN News UNCY News INCR News TCRX News MCRB News ANRO News MIST News MNOV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PASG) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredWashington Is Broke—and Eyeing Your Savings NextWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Passage Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Passage Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PASG Stock Free PASG Stock Alerts